398 related articles for article (PubMed ID: 17492653)
1. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate.
Whittington K; Connors B; King K; Assinder S; Hogarth K; Nicholson H
Prostate; 2007 Jul; 67(10):1132-42. PubMed ID: 17492653
[TBL] [Abstract][Full Text] [Related]
2. Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP.
King KJ; Nicholson HD; Assinder SJ
Prostate; 2006 Jan; 66(1):105-14. PubMed ID: 16114065
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin, oxytocin-associated neurophysin and the oxytocin receptor in the human prostate.
Whittington K; Assinder S; Gould M; Nicholson H
Cell Tissue Res; 2004 Nov; 318(2):375-82. PubMed ID: 15459766
[TBL] [Abstract][Full Text] [Related]
4. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
5. Changing caveolin-1 and oxytocin receptor distribution in the ageing human prostate.
Herbert Z; Bötticher G; Aschoff A; Sendemir E; Zermann DH; Arnold R; Mall G; Jirikowski GF
Anat Histol Embryol; 2007 Oct; 36(5):361-5. PubMed ID: 17845226
[TBL] [Abstract][Full Text] [Related]
6. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of androgen binding protein, oxytocin receptor, caveolin 1 and proliferation marker p21 in benign prostate hyperplasia.
Sendemir E; Herbert Z; Sivukhina E; Zermann DH; Arnold R; Jirikowski GF
Anat Histol Embryol; 2008 Oct; 37(5):325-31. PubMed ID: 18312604
[TBL] [Abstract][Full Text] [Related]
8. Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas.
Cassoni P; Marrocco T; Sapino A; Allia E; Bussolati G
Int J Oncol; 2004 Oct; 25(4):899-904. PubMed ID: 15375538
[TBL] [Abstract][Full Text] [Related]
9. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells.
Assinder SJ
Prostate; 2008 Feb; 68(2):115-21. PubMed ID: 18008328
[TBL] [Abstract][Full Text] [Related]
11. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
[TBL] [Abstract][Full Text] [Related]
12. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
Bromfield GP; Meng A; Warde P; Bristow RG
Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin--its role in male reproduction and new potential therapeutic uses.
Thackare H; Nicholson HD; Whittington K
Hum Reprod Update; 2006; 12(4):437-48. PubMed ID: 16436468
[TBL] [Abstract][Full Text] [Related]
14. Negative control of epithelial cell proliferation by prostatic stroma.
Kooistra A; König JJ; Romijn JC; Schröder FH
Anticancer Res; 1991; 11(4):1495-500. PubMed ID: 1720936
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
He D; Falany CN
Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
[TBL] [Abstract][Full Text] [Related]
16. Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer.
Abdul M; Mccray SD; Hoosein NM
Acta Oncol; 2008; 47(8):1546-50. PubMed ID: 18607852
[TBL] [Abstract][Full Text] [Related]
17. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia].
Santa María Margalef A; Paciucci Barzanti R; Reventós Puigjaner J; Morote Robles J; Thomson Okatsu TM
Arch Esp Urol; 2003 May; 56(4):369-78. PubMed ID: 12830609
[TBL] [Abstract][Full Text] [Related]
18. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines.
Webber MM; Bello D; Quader S
Prostate; 1996 Dec; 29(6):386-94. PubMed ID: 8977636
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the regulation of prostatic oxytocin by gonadal steroids in the rat.
Jenkin L; Nicholson HD
J Androl; 1999; 20(1):80-7. PubMed ID: 10100477
[TBL] [Abstract][Full Text] [Related]
20. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance.
Tam CW; Chan KW; Liu VW; Pang B; Yao KM; Shiu SY
J Pineal Res; 2008 Nov; 45(4):403-12. PubMed ID: 18637986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
